Capecitabine-induced stomatitis: a likely pathogenetic mechanism of oral lichenoid mucositis.
Mignogna
Michele D
MD
Fortuna
Giulio
G
Falleti
Jessica
J
Leuci
Stefania
S
D000278:Administration, Buccal; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D001623:Betamethasone / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy; D000069287:Capecitabine; D002710:Chlorhexidine / Q000008:administration & dosage; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D013280:Stomatitis / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology
D000964:Antimetabolites, Antineoplastic; D005938:Glucocorticoids; D003841:Deoxycytidine; D000069287:Capecitabine; D001623:Betamethasone; D002710:Chlorhexidine; D005472:Fluorouracil